« Richard Garozzo, Senior Composites Engineer in the Polymer Nanocomposites and Composites Group, University of Dayton Research Institute, and Manager, UDRI’s Center for Multifunctional Polymer Nanocomposites and Devices, 3-1-07 | Main | Dr. Edwin C. Krupp, Astronomer and Director of Griffith Observatory, 3-1-07 »
March 01, 2007
Dr. Barbara Hempstead, O. Wayne Isom Professor of Medicine and Co-Division Chief, Division of Hematology and Medical Oncology, Weill Medical College of Cornell University and New York-Presbyterian Hospital, 3-1-07
Read the transcript of the SCIENCE AND SOCIETY interview with Dr. Barbara Hempstead
Download Adobe Reader here
Dr. Barbara L. Hempstead is a member of the Association of American Physicians and the American Society for Clinical Investigation. Among the honors and awards she has received are the Clinical Investigator Award from the National Cancer Institute and the Clinical Scientist Award in Translational Science from the Burroughs Wellcome Fund.
Dr. Hempstead has authored more than 70 scientific articles, with two papers published in Science and one in Nature in the last four years. Five of her articles are rated “Must Read” or higher in the Faculty of 1000 rankings. She has been Editor of the Journal of Investigational Medicine, and is a member of the editorial board of Journal of Biological Chemistry. She was Vice Chair for the Gordon Conference “Neurotrophic Factors” in 2003, and Chair in 2005.
The primary focus of Dr. Hempstead’s basic research is the role of growth factors called neurotrophins, and their receptors in human physiology and pathology. While some of her work has revealed how neurotrophins function in the arena in which most people study them, i.e., the brain and nervous system, her lab has conducted pioneering research in the roles that neurotrophins play outside the nervous system - in the cardiovascular system and on stem and progenitor cells that form blood. A major focus has been in identifying the actions of neurotrophins in promoting blood vessel growth, with implications in wound healing, atherosclerotic disease and tumor biology.
Weill Cornell Medical College—located in New York City—is committed to excellence in research, teaching, patient care and the advancement of the art and science of medicine. The Medical College, which is a principal academic affiliate of New York-Presbyterian Hospital, offers an innovative curriculum that integrates the teaching of basic and clinical sciences, problem-based learning, office-based preceptorships, and primary care and doctoring courses. Physicians and scientists of Weill Cornell Medical College are engaged in cutting-edge research in such areas as stem cells, genetics and gene therapy, geriatrics, neuroscience, structural biology, cardiovascular medicine, AIDS, obesity, cancer and psychiatry—and continue to delve ever deeper into the molecular basis of disease in an effort to unlock the mysteries behind the human body and the malfunctions that result in serious medical disorders.
Weill Cornell Medical College is the birthplace of many medical advances—from the development of the Pap test for cervical cancer to the synthesis of penicillin, the first successful embryo-biopsy pregnancy and birth in the U.S., and most recently, the world’s first clinical trial for gene therapy for Parkinson’s disease. Weill Cornell’s Physician Organization includes 650 clinical faculty, who provide the highest quality of care to their patients.
Posted by David Lemberg at March 1, 2007 08:25 AM Return to SCIENCE AND SOCIETY home page